Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00214292 · ClinicalTrials.gov registry record · NA

Evaluation of Breast Cancer Surgical Margins Using Optical Spectroscopy

A NA study of Breast Cancer, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT00214292: Completed NA study of Breast Cancer, sponsored by University of Wisconsin, Madison.

NCT00214292 is a NA study of Breast Cancer that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 20 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00214292, a NA study of Breast Cancer, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study will apply optical spectroscopy to intraoperative margin assessment during surgery for breast cancer. We hypothesize that a combination of fluorescence spectroscopy and diffuse reflectance spectroscopy will reliably detect involved surgical margins. Twenty patients with ductal carcinoma in-situ will undergo a standard lumpectomy followed by scanning with a sterile optical spectroscopy probe. Frozen sections from the surgical cavity will be used to evaluate the margins. Optical spectroscopy data will be categorized as benign or malignant using a statistical algorithm and the results will be compared with the frozen and permanent section results.

Conditions Studied

Interventions

  • PROCEDURE fluorescence spectroscopy and diffuse spectroscopy

Study Locations (1)

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2005-05
Est. Completion 2011-03
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT00214292 record still lists

NCT00214292 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which fluorescence spectroscopy and diffuse spectroscopy is the first listed.

NCT00214292 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT00214292 about?

NCT00214292 is a clinical study titled "Evaluation of Breast Cancer Surgical Margins Using Optical Spectroscopy". This study will apply optical spectroscopy to intraoperative margin assessment during surgery for breast cancer. We hypothesize that a combination of fluorescence spectroscopy and diffuse reflectance spectroscopy will reliably detect involved surgical margins. Twenty patients with ductal carcinoma i...

What is the current status of trial NCT00214292?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2005-05. Estimated completion is 2011-03.

What conditions does trial NCT00214292 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00214292?

The interventions under investigation include: fluorescence spectroscopy and diffuse spectroscopy (PROCEDURE).

Who is sponsoring clinical trial NCT00214292?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00214292 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00214292's enrollment target sits among peer trials

20 1079th of 1224 higher than 112 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00214292, the US trial registry maintained by the National Library of Medicine. NCT00214292 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.